Table D.1.

Summary table of the question number and related mandate grouped by disease

Disease	Mandate	Output number	Question number
AI	M‐2014‐0316	ON‐3941	EFSA‐Q‐2014‐00838
	M‐2015‐0079	EN‐1142	EFSA‐Q‐2016‐00792
		EN‐1282	EFSA‐Q‐2017‐00573
		EN‐1283	EFSA‐Q‐2017‐00574
		EN‐1284	EFSA‐Q‐2017‐00575
		EN‐1285	EFSA‐Q‐2017‐00576
		EN‐1286	EFSA‐Q‐2017‐00577
		EN‐1287	EFSA‐Q‐2017‐00578
		ON‐4687	EFSA‐Q‐2016‐00777
		ON‐4991	EFSA‐Q‐2015‐00214
			EFSA‐Q‐2016‐00348
	M‐2015‐0240	ON‐4891	EFSA‐Q‐2016‐00599
	M‐2017‐0062	ON‐5018	EFSA‐Q‐2017‐00229
		ON‐5141	EFSA‐Q‐2017‐00649
ASF	M‐2014‐0057	ON‐3616	EFSA‐Q‐2014‐00149
	M‐2014‐0079	ON‐4795	EFSA‐Q‐2017‐00158
	M‐2014‐0323	EN‐843	EFSA‐Q‐2015‐00401
		ON‐4163	EFSA‐Q‐2014‐00897
	M‐2016‐0048	EN‐1312	EFSA‐Q‐2017‐00155
		ON‐4732	EFSA‐Q‐2016‐00152
		ON‐5068	EFSA‐Q‐2017‐00154
EM	M‐2012‐0200	EN‐366	EFSA‐Q‐2012‐00746
		ON‐2973	EFSA‐Q‐2012‐00640
		ON‐3465	EFSA‐Q‐2013‐00535
		ON‐3875	EFSA‐Q‐2013‐00536
		ON‐4310	EFSA‐Q‐2013‐00537
		ON‐4649	EFSA‐Q‐2014‐00734
		ON‐5051	EFSA‐Q‐2017‐00403
	M‐2014‐0287	ON‐4035	EFSA‐Q‐2014‐00727
		ON‐5051	EFSA‐Q‐2017‐00697
	M‐2014‐0288	ON‐4373	EFSA‐Q‐2014‐00728
LSD	M‐2013‐0332	ON‐3986	EFSA‐Q‐2013‐00917
	M‐2016‐0122	ON‐4573	EFSA‐Q‐2016‐00384
	M‐2016‐0170	ON‐4773	EFSA‐Q‐2016‐00542
		ON‐5176	EFSA‐Q‐2016‐00625